During the past decade, Sichuan Province Cancer Hospital/Department of Pulmonary Tumor conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sichuan Province Cancer Hospital/Department of Pulmonary Tumor" #1 collaborator was "OxOnc Development LP" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Sichuan Province Cancer Hospital/Department of Pulmonary Tumor" are "ALK or ROS1-positive NSCLC" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Crizotinib" (1 trials), "NSCLC (Non-small Cell Lung Cancer)" (1 trials) and "Non Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Sichuan Province Cancer Hospital/Department of Pulmonary Tumor" in a lesser frequency.

Most popular intervention types in "Sichuan Province Cancer Hospital/Department of Pulmonary Tumor" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Crizotinib" (3 trials), "Lorlatinib" (1 trials), "Pemetrexed/Carboplatin" (1 trials) and "Pemetrexed/Cisplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sichuan Province Cancer Hospital/Department of Pulmonary Tumor" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Sichuan Province Cancer Hospital/Department of Pulmonary Tumor". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Sichuan Province Cancer Hospital/Department of Pulmonary Tumor, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sichuan Province Cancer Hospital/Department of Pulmonary Tumor, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".